Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
about
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastic osteogenesis and its molecular mechanism.Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.
P2860
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en-gb
type
label
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en-gb
prefLabel
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en-gb
P2860
P1476
Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.
@en
P2093
Noemi Busquets-Perez
P2860
P356
10.1517/14728214.2013.752815
P407
P577
2012-12-20T00:00:00Z
P6179
1046634131